Tonix Pharmaceuticals
TNXP
32 hedge funds and large institutions have $4.85M invested in Tonix Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
2,976% more capital invested
Capital invested by funds: $158K → $4.85M (+$4.69M)
400% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 4
100% more funds holding
Funds holding: 16 → 32 (+16)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.07% more ownership
Funds ownership: 0.01% → 0.08% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.23M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$386K |
| 3 |
Jane Street
New York
|
+$340K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$332K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$318K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.1K |
| 2 |
VF
Virtu Financial
New York
|
-$15K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.3K |
| 4 |
MG
Marex Group
London,
|
-$4.88K |
| 5 |
LPL Financial
San Diego,
California
|
-$3.12K |
TNXP Hedge Fund Activity: Q4 2024 in Review
32 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2024, worth a combined $4.85M — up 2,976% from $158K a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new TNXP positions and 4 closed out — a net gain of 16 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $1.23M. The largest seller was Millennium Management, cutting an estimated $16.1K.
- 32 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2024, up from 16 in Q3 2024.
- Funds reported $4.85M of Tonix Pharmaceuticals stock for Q4 2024, up 2,976% quarter-over-quarter.
- 20 funds opened new Tonix Pharmaceuticals positions in Q4 2024 and 4 closed out, a net change of +16 holders.
- The largest Tonix Pharmaceuticals buyer in Q4 2024 was BlackRock, an estimated $1.23M added.
- The largest Tonix Pharmaceuticals seller in Q4 2024 was Millennium Management, an estimated $16.1K sold.
Based on aggregated 13F filings for Q4 2024.